Kids Irritated Eye Relief

Product NDC
59262-362
11-digit product format
592620362
Labeler code
59262
Product ID
59262-362_38335b81-bcd9-4b48-8d4e-fb2fe4aa27fe
Type
HUMAN OTC DRUG
Nonproprietary name
Belladonna and Euphrasia and Hepar Sulphuris and Thuja
Dosage form
LIQUID
Route
OPHTHALMIC
Labeler
Similasan Corporation
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2013-07-02
Marketing end
0000-00-00
Substance
ATROPA BELLADONNA; EUPHRASIA STRICTA; CALCIUM SULFIDE; PLATYCLADUS ORIENTALIS LEAF
Active strength
6 [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct59262-362DDiscontinued by firm2026-10-05
excluded packagepackage59262-36259262-362-11DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage59262-362-11DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage59262-362-11DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage59262-362-11DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage59262-362-11DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage59262-362-11DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage59262-362-11DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage59262-362-11DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage59262-362-11DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage59262-362-11DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage59262-362-11DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage59262-362-11DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage59262-362-11DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage59262-362-11IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage59262-362-11IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage59262-362-11IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage59262-362-11IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage59262-362-11IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage59262-362-11IInactivated by FDA9bebd1f3094a…5416666fcb17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59262-362-112023-03-03C16284748780-19d75b9cf-d76c-f424-e053-dadaa90a57ceKids Irritated Eye Relief
59262-362-112020-01-31C16284748780-19d75b9cf-d76c-f424-e053-dadaa90a57ceKids Irritated Eye Relief

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59262-362-11ML - Milliliter59262-362a8dd631e-7370-4538-9f21-6fa3634c985112022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ATROPA BELLADONNAACTIVE INGREDIENTWQZ3G9PF0HKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
CALCIUM SULFIDEACTIVE INGREDIENT1MBW07J51QKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
EUPHRASIA STRICTAACTIVE INGREDIENTC9642I91WLKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
PLATYCLADUS ORIENTALIS LEAFACTIVE INGREDIENT32E5V7G32BKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
ATROPA BELLADONNAACTIVE MOIETYWQZ3G9PF0HKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
CALCIUM SULFIDEACTIVE MOIETY1MBW07J51QKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
EUPHRASIA STRICTAACTIVE MOIETYC9642I91WLKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
PLATYCLADUS ORIENTALIS LEAFACTIVE MOIETY32E5V7G32BKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
SILVER SULFATEINACTIVE INGREDIENT8QG6HV4ZPOKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
SODIUM NITRATEINACTIVE INGREDIENT8M4L3H2ZVZKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4
WATERINACTIVE INGREDIENT059QF0KO0RKIDS IRRITATED EYE RELIEF (BELLADONNA AND EUPHRASIA AND HEPAR SULPHURIS AND THUJA) LIQUID [SIMILASAN CORPORATION]4